Boston, USA – A recent clinical trial has revealed the effectiveness of a new experimental drug in improving kidney transplant outcomes.
It demonstrated superior performance compared to the standard treatment used for decades.
This could pave the way for the development of safer and more effective methods to prevent kidney transplant rejection.
Promising results in clinical trials
Data presented by researchers at the American Transplantation Society meeting in Boston showed
that an experimental drug called tigobart, developed by Elidon Pharmaceuticals,
achieved positive results in kidney transplant patients during a 12-month study.
The researchers explained that patients who received the new treatment experienced improved kidney function
from the first month after transplantation, compared to patients who received the standard drug tacrolimus.
Different treatment mechanism
The drug tigobart targets a specific immune pathway known as CD40L.
This allows it to suppress the immune cells responsible for organ
transplant rejection without affecting the entire immune system.
This approach distinguishes it from traditional medications.
In contrast, tacrolimus, used since the 1990s, suppresses the immune system more broadly.
This can lead to side effects and complications that affect the efficiency of the transplanted organ and the long-term quality of life of patients.
New prospects for kidney transplant patients
The study results showed no cases of transplant loss or biopsy-confirmed
acute rejection after the first six months in patients treated with tigobart.
In contrast, the group treated with tacrolimus experienced higher rates of these complications.
Researchers believe these findings represent a significant step toward developing a new generation of immunosuppressants.
This new generation could contribute to extending the lifespan of transplanted kidneys and reducing complications.
Furthermore, it could improve the quality of life for thousands of patients
who require lifelong immunosuppressive therapy after kidney transplantation.
